1. Home
  2. KSS vs BLFS Comparison

KSS vs BLFS Comparison

Compare KSS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kohl's Corporation

KSS

Kohl's Corporation

HOLD

Current Price

$23.02

Market Cap

2.5B

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$25.40

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSS
BLFS
Founded
1962
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.2B
IPO Year
1992
1989

Fundamental Metrics

Financial Performance
Metric
KSS
BLFS
Price
$23.02
$25.40
Analyst Decision
Sell
Strong Buy
Analyst Count
13
4
Target Price
$15.55
$31.50
AVG Volume (30 Days)
7.1M
360.9K
Earning Date
11-25-2025
11-06-2025
Dividend Yield
2.16%
N/A
EPS Growth
N/A
N/A
EPS
1.73
N/A
Revenue
$15,751,000,000.00
$100,144,000.00
Revenue This Year
N/A
$20.67
Revenue Next Year
N/A
$14.13
P/E Ratio
$13.41
N/A
Revenue Growth
N/A
87.53
52 Week Low
$6.04
$19.10
52 Week High
$25.22
$29.62

Technical Indicators

Market Signals
Indicator
KSS
BLFS
Relative Strength Index (RSI) 60.58 48.48
Support Level $21.84 $24.11
Resistance Level $23.41 $25.98
Average True Range (ATR) 1.16 0.82
MACD -0.23 0.05
Stochastic Oscillator 45.90 62.41

Price Performance

Historical Comparison
KSS
BLFS

About KSS Kohl's Corporation

Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: